IGC Pharma (IGC) Cash & Current Investments (2010 - 2026)
IGC Pharma (IGC) reported Cash & Current Investments of $263000.0 for Q1 2026, down 35.06% year-over-year from $405000.0 in Q1 2025, and down 73.05% quarter-over-quarter from $976000.0 in Q4 2025.
IGC Pharma (IGC) Cash & Current Investments (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has 17 years of Cash & Current Investments data on file, last reported at $263000.0 in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $263000.0, down 35.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $263000.0 (down 35.06% YoY), and the FY2026 annual result was $263000.0, down 35.06% from the prior year.
- Cash & Current Investments fell to $263000.0 in Q1 2026 per IGC's latest filing, from $976000.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $10.5 million in Q1 2022 and troughed at $263000.0 in Q1 2026.
- A 5-year average of $2.9 million and a median of $1.5 million in 2024 frame the typical range for Cash & Current Investments.
- On a YoY basis, Cash & Current Investments climbed as much as 107.66% in 2025 and fell as far as 75.11% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $5.1 million in 2022, then slumped by 73.09% to $1.4 million in 2023, then tumbled by 65.89% to $470000.0 in 2024, then surged by 107.66% to $976000.0 in 2025, then slumped by 73.05% to $263000.0 in 2026.
- Business Quant data shows IGC's Cash & Current Investments at $263000.0 in Q1 2026, $976000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | 263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 976,000.00 |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 454,000.00 |
| Mar 31, 2025 | 405,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 11.94 Mn |
| Sep 30, 2021 | 14.40 Mn |
| Jun 30, 2021 | 13.32 Mn |